Global Single Nucleotide Polymorphism Genotyping Market to grow with a CAGR of 17.20 %
Increasing
healthcare infrastructure and a supportive regulatory environment are the major
drivers for the Global Single Nucleotide Polymorphism Genotyping Market.
According
to TechSci Research report, “Global Single Nucleotide Polymorphism
Genotyping Market Industry Size, Share, Trends, Competition, Opportunity and
Forecast, 2018-2028”, Global
Single Nucleotide Polymorphism Genotyping Market has valued at USD 8.15 billion
in 2022 and is anticipated to witness an impressive growth in the forecast
period with a CAGR of 17.20% through 2028. This can be due to collaborations
and partnerships among leading companies with a diverse approach to merge the
expertise of individual companies and to strengthen their position in the
market. Advancements in genomic research have had a profound impact on Single
Nucleotide Polymorphism (SNP) Genotyping. These developments have significantly
improved the accuracy, throughput, and cost-effectiveness of SNP genotyping,
making it a fundamental tool in the field of genomics. Genomic research has
witnessed the development of high-throughput genotyping technologies.
Researchers can now simultaneously genotype hundreds of thousands or even
millions of SNPs in a single experiment, allowing for comprehensive studies of
genetic variations across large populations. Genome-Wide Association Studies
(GWAS) have become a standard approach in genomics research. These studies
involve scanning the entire genome for SNPs associated with specific traits or
diseases. The availability of extensive SNP genotyping arrays and data has
facilitated the discovery of thousands of SNP-trait associations. The creation
of extensive reference databases, such as the 1000 Genomes Project and the
Genome Aggregation Database (gnomAD), has provided researchers with
comprehensive catalogs of genetic variations, including SNPs. These databases
serve as valuable resources for SNP selection and interpretation. The
availability of Whole Genome Sequencing (WGS) data has allowed for the
identification of rare and novel SNPs. Researchers can now delve deeper into
the human genome and identify previously unknown genetic variants.
Browse
over XX market data Figures and spread through XX
Pages and an in-depth TOC on " Global Single Nucleotide Polymorphism Genotyping Market”
In February 2021, Thermo Fisher Scientific,
the global leader in scientific solutions, has unveiled the Applied Biosystems
TaqMan SARS-CoV-2 Mutation Panel. This panel offers a customizable selection of
22 verified real-time PCR assays designed for the identification of SARS-CoV-2
mutations. These assays empower the monitoring of variants responsible for COVID-19
infections in specific regions worldwide and grant laboratories the flexibility
to select the mutations they wish to track. Given the numerous mutations in
SARS-CoV-2, some of which may affect the efficacy of treatments and vaccines,
ongoing surveillance of viral changes is of paramount importance. The TaqMan
SARS-CoV-2 Mutation Panel is highly adaptable, capable of analysing a small or
large number of samples to identify one or multiple mutations. This versatility
allows laboratories to meet varying testing requirements using the real-time
PCR instruments they already have. The panel delivers results in approximately
one hour and utilizes the reliable TaqMan SNP genotyping assay technology,
ensuring efficient mutation detection and differentiation.
Interoperability
is indeed a challenge in the Global Single Nucleotide Polymorphism (SNP)
Genotyping Market. Interoperability refers to the ability of different SNP
genotyping platforms, instruments, and data to work seamlessly together. The
lack of interoperability can hinder the efficient exchange of genetic
information, data analysis, and the integration of SNP genotyping results into
broader research and healthcare contexts. There are various SNP genotyping
platforms and technologies available, including microarrays, next-generation
sequencing, real-time PCR, and others. These platforms often have proprietary
data formats and analysis pipelines, making it challenging to integrate data
from different sources. The absence of standardized data formats and reporting
mechanisms can impede data sharing and collaboration. Different genotyping
platforms may use unique data formats, which require conversion and
compatibility efforts. Integrating SNP genotyping data with other types of
biological and clinical data, such as gene expression data or electronic health
records, can be complex due to issues of data format, quality, and the need for
appropriate data management and integration tools.
Global Single Nucleotide Polymorphism Genotyping
Market is segmented based on Technology, Application, and by region.
Based on the Technology, Global Single Nucleotide
Polymorphism Genotyping Market is segmented into TaqMan SNP Genotyping, Massarray SNP
Genotyping, SNP GeneChip Arrays, Others. MassArray SNP genotyping, also known as MALDI-TOF (Matrix-Assisted
Laser Desorption/Ionization-Time of Flight) SNP genotyping, is a
high-throughput method for identifying and characterizing single nucleotide
polymorphisms (SNPs) in DNA samples. This technique is widely used in genetics
and genomics research, clinical diagnostics, and various other applications. MassArray
SNP genotyping is based on the principle of mass spectrometry, which involves
the measurement of the mass-to-charge ratio (m/z) of ions. In this technique,
each SNP is characterized by its unique mass signature. MassArray genotyping
uses a matrix-assisted laser desorption/ionization (MALDI) time-of-flight mass
spectrometer to analyze the DNA samples.
Based on Region, North America held the largest share in the Global Single
Nucleotide Polymorphism Genotyping Market. North America has been at the
forefront of integrating genomics into clinical practice. Initiatives like the
Precision Medicine Initiative in the United States have accelerated the
adoption of SNP genotyping in healthcare for personalized medicine. The region's
well-established healthcare infrastructure, including electronic health records
and medical databases, facilitates the integration of genetic data into patient
care and research. North America has a well-educated and skilled workforce in
genomics, genetics, and biotechnology. Leading scientists, researchers, and
experts in this field are based in the region.
The demand for SNP genotyping is high in North America due to a large
patient population, a focus on understanding the genetic basis of diseases, and
the need for advanced diagnostic and research tools.
Some of the major companies
operating in the Global Single
Nucleotide Polymorphism Genotyping Market include:
- Agilent
Technologies Inc.
- Bio-Rad
Laboratories Inc.
- Danaher
Corporation
- Douglas
Scientific LLC
- Illumina
Inc.
- Life
Technologies Corp.
- Luminex
Corp
- Promega Corporation
- Thermo
Fischer Scientific Inc.
- Fluidigm
Corporation
Download Free Sample Report
Customers can also request
for 10% free customization on this report
“Certain areas, particularly in North
America, are projected to exert significant demand for Single Nucleotide
Polymorphism Genotyping. The growth in the competitive landscape and the
presence of well-established companies in the market, committed to enhance the overall
wellbeing of people each year, are expected to contribute to a remarkable
growth of the Global Single Nucleotide Polymorphism Genotyping Market in the
forecast period," said Mr. Karan Chechi, Research Director with TechSci
Research, a research-based Global management consulting firm.
Global Single
Nucleotide Polymorphism Genotyping Market by Technology (TaqMan SNP Genotyping, Massarray
SNP Genotyping, SNP GeneChip Arrays, Others), By Application (Animal Genetics, Plant Improvement, Diagnostic Research, Pharmaceuticals
and Pharmacogenomics, Agricultural Biotechnology, Others), By Region, By Competition Forecast &
Opportunities, 2018-2028F has evaluated the future growth potential
of Global Single Nucleotide Polymorphism Genotyping Market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide innovative market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Single Nucleotide Polymorphism
Genotyping Market.
Contact
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +13322586602
Email: [email protected]
Website: www.techsciresearch.com